BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38601438)

  • 21. Determinants of Aurora kinase B inhibitor sensitivity in small cell lung cancer.
    Duan L; Maki CG
    Transl Lung Cancer Res; 2024 Feb; 13(2):223-228. PubMed ID: 38496702
    [No Abstract]   [Full Text] [Related]  

  • 22. [Aurora kinase-B silencing promotes apoptosis of osteosarcoma 143B cells by ULK1 phosphorylation-induced autophagy].
    Wu X; Liu J; Song H; Yang Q; Ying H; Liu Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Sep; 40(9):1273-1279. PubMed ID: 32990233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of Aurora Kinase B Is Correlated with Diagnosis and Poor Prognosis in Hepatocellular Carcinoma.
    Zhang J; Ma J; Li Y; An Y; Du W; Yang Q; Huang M; Cai X
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promising Therapy in Lung Cancer: Spotlight on Aurora Kinases.
    Galetta D; Cortes-Dericks L
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33202573
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Sakai S; Izumi H; Yoshiura Y; Nakayama Y; Yamaguchi T; Harada Y; Koi C; Kurata H; Morimoto Y
    Oncol Lett; 2016 Nov; 12(5):4263-4269. PubMed ID: 27895801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Aurora kinase B relocation blocker LXY18 triggers mitotic catastrophe selectively in malignant cells.
    Kalashova J; Yang C; Li H; Long Y; Yu D; Zhang T; Liu X; Choudhry N; Shi Q; Allen TD
    PLoS One; 2023; 18(10):e0293283. PubMed ID: 37903144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma.
    Bogen D; Wei JS; Azorsa DO; Ormanoglu P; Buehler E; Guha R; Keller JM; Mathews Griner LA; Ferrer M; Song YK; Liao H; Mendoza A; Gryder BE; Sindri S; He J; Wen X; Zhang S; Shern JF; Yohe ME; Taschner-Mandl S; Shohet JM; Thomas CJ; Martin SE; Ambros PF; Khan J
    Oncotarget; 2015 Nov; 6(34):35247-62. PubMed ID: 26497213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel therapeutic combination sequentially targeting aurora B and Bcl-xL in hepatocellular carcinoma.
    Matsunaga H; Tanaka S; Aihara A; Ogawa K; Matsumura S; Ban D; Ochiai T; Irie T; Kudo A; Nakamura N; Arii S; Tanabe M
    Ann Surg Oncol; 2015 Sep; 22(9):3079-86. PubMed ID: 25524010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of Aurora Kinase inhibition on thyroid cancer growth and sensitivity to MAPK-directed therapies.
    Hicks HM; Nassar VL; Lund J; Rose MM; Schweppe RE
    Cancer Biol Ther; 2024 Dec; 25(1):2332000. PubMed ID: 38521968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide CRISPR screen uncovers a synergistic effect of combining Haspin and Aurora kinase B inhibition.
    Huang M; Feng X; Su D; Wang G; Wang C; Tang M; Paulucci-Holthauzen A; Hart T; Chen J
    Oncogene; 2020 May; 39(21):4312-4322. PubMed ID: 32300176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, and evaluation of dual EGFR/AURKB inhibitors as anticancer agents for non-small cell lung cancer.
    Kurup S; Gesinski D; Assaad K; Reynolds A
    Bioorg Med Chem Lett; 2024 Mar; 100():129612. PubMed ID: 38199330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct Phosphorylation and Stabilization of MYC by Aurora B Kinase Promote T-cell Leukemogenesis.
    Jiang J; Wang J; Yue M; Cai X; Wang T; Wu C; Su H; Wang Y; Han M; Zhang Y; Zhu X; Jiang P; Li P; Sun Y; Xiao W; Feng H; Qing G; Liu H
    Cancer Cell; 2020 Feb; 37(2):200-215.e5. PubMed ID: 32049046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735.
    Hook KE; Garza SJ; Lira ME; Ching KA; Lee NV; Cao J; Yuan J; Ye J; Ozeck M; Shi ST; Zheng X; Rejto PA; Kan JL; Christensen JG; Pavlicek A
    Mol Cancer Ther; 2012 Mar; 11(3):710-9. PubMed ID: 22222631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma.
    Mahadevan D; Stejskal A; Cooke LS; Manziello A; Morales C; Persky DO; Fisher RI; Miller TP; Qi W
    Clin Cancer Res; 2012 Apr; 18(8):2210-9. PubMed ID: 22374334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bcl-XL represents a druggable molecular vulnerability during aurora B inhibitor-mediated polyploidization.
    Shah OJ; Lin X; Li L; Huang X; Li J; Anderson MG; Tang H; Rodriguez LE; Warder SE; McLoughlin S; Chen J; Palma J; Glaser KB; Donawho CK; Fesik SW; Shen Y
    Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12634-9. PubMed ID: 20616035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SIX3, a tumor suppressor, inhibits astrocytoma tumorigenesis by transcriptional repression of AURKA/B.
    Yu Z; Sun Y; She X; Wang Z; Chen S; Deng Z; Zhang Y; Liu Q; Liu Q; Zhao C; Li P; Liu C; Feng J; Fu H; Li G; Wu M
    J Hematol Oncol; 2017 Jun; 10(1):115. PubMed ID: 28595628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aurora A-Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy.
    Du J; Yan L; Torres R; Gong X; Bian H; Marugán C; Boehnke K; Baquero C; Hui YH; Chapman SC; Yang Y; Zeng Y; Bogner SM; Foreman RT; Capen A; Donoho GP; Van Horn RD; Barnard DS; Dempsey JA; Beckmann RP; Marshall MS; Chio LC; Qian Y; Webster YW; Aggarwal A; Chu S; Bhattachar S; Stancato LF; Dowless MS; Iversen PW; Manro JR; Walgren JL; Halstead BW; Dieter MZ; Martinez R; Bhagwat SV; Kreklau EL; Lallena MJ; Ye XS; Patel BKR; Reinhard C; Plowman GD; Barda DA; Henry JR; Buchanan SG; Campbell RM
    Mol Cancer Ther; 2019 Dec; 18(12):2207-2219. PubMed ID: 31530649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knocking down the expression of Aurora-A gene inhibits cell proliferation and induces G2/M phase arrest in human small cell lung cancer cells.
    Lu Y; Liu Y; Jiang J; Xi Z; Zhong N; Shi S; Wang J; Wei X
    Oncol Rep; 2014 Jul; 32(1):243-9. PubMed ID: 24841948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aurora kinase B disruption suppresses pathological retinal angiogenesis by affecting cell cycle progression.
    Zhu W; Gui X; Zhou Y; Gao X; Zhang R; Li Q; Zhang H; Zhao J; Cui X; Gao G; Tang H; Huan C; Pan D; Song H; Zhou Z; Shen W
    Exp Eye Res; 2024 Feb; 239():109753. PubMed ID: 38142764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorylation and activation of cell division cycle associated 8 by aurora kinase B plays a significant role in human lung carcinogenesis.
    Hayama S; Daigo Y; Yamabuki T; Hirata D; Kato T; Miyamoto M; Ito T; Tsuchiya E; Kondo S; Nakamura Y
    Cancer Res; 2007 May; 67(9):4113-22. PubMed ID: 17483322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.